|Bid||92.50 x 900|
|Ask||94.70 x 900|
|Day's range||92.84 - 94.98|
|52-week range||92.63 - 136.48|
|Beta (5Y monthly)||1.18|
|PE ratio (TTM)||11.03|
|Earnings date||27 Apr 2022 - 02 May 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||122.25|
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
DaVita Inc. ( NYSE:DVA ) shareholders have seen the share price descend 14% over the month. But that doesn't undermine...
Despite strength in dialysis patient service revenues, DaVita (DVA) records an overall soft Q1 performance.